Literature DB >> 7543581

Mimicry of the immunodominant conformation-dependent antigenic site of hepatitis A virus by motifs selected from synthetic peptide libraries.

S Mattioli1, L Imberti, R Stellini, D Primi.   

Abstract

Hepatitis A virus (HAV) is a positive-strand RNA virus with a genome length of approximately 7,480 nucleotides. Although HAV morphogenesis is thought to be similar to that of poliovirus, the prototype picornavirus, the complete characterization of the antigenic structure of this virus remains elusive. All the available evidences, however, support the existence, on HAV virions and empty capsids, of an immunodominant neutralization antigenic site which is conformation dependent and whose structure involves residues of both VP1 and VP3 capsid proteins. This particular feature and the difficulty of obtaining high virus yield in tissue cultures make HAV an ideal target for developing synthetic peptides that simulate the structure of its main antigenic determinant. To this end we utilized, in the present work, the divide-couple-recombine approach to generate a random library composed of millions of different hexapeptides. This vast library was screened with a well-characterized anti-HAV monoclonal antibody. By this strategy we identified a peptide that reacted specifically with monoclonal and polyclonal anti-HAV antibodies and, in mice, induced a specific anti-virus immune response. Furthermore, the peptide could also be used in an enzyme-linked immunosorbent assay for revealing a primary immunoglobulin M immune response in sera of acutely infected human patients. Interestingly, no sequence homology was found between the identified peptide and the HAV capsid proteins VP1 and VP3. Collectively, these data represent an additional important paradigm of a mimotope capable of mimicking an antigenic determinant with unknown tertiary structure.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7543581      PMCID: PMC189366     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  26 in total

1.  Searching for peptide ligands with an epitope library.

Authors:  J K Scott; G P Smith
Journal:  Science       Date:  1990-07-27       Impact factor: 47.728

2.  Generation and use of synthetic peptide combinatorial libraries for basic research and drug discovery.

Authors:  R A Houghten; C Pinilla; S E Blondelle; J R Appel; C T Dooley; J H Cuervo
Journal:  Nature       Date:  1991-11-07       Impact factor: 49.962

3.  A new type of synthetic peptide library for identifying ligand-binding activity.

Authors:  K S Lam; S E Salmon; E M Hersh; V J Hruby; W M Kazmierski; R J Knapp
Journal:  Nature       Date:  1991-11-07       Impact factor: 49.962

4.  Strategies for epitope analysis using peptide synthesis.

Authors:  H M Geysen; S J Rodda; T J Mason; G Tribbick; P G Schoofs
Journal:  J Immunol Methods       Date:  1987-09-24       Impact factor: 2.303

5.  Identification of an immunodominant antigenic site involving the capsid protein VP3 of hepatitis A virus.

Authors:  L H Ping; R W Jansen; J T Stapleton; J I Cohen; S M Lemon
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

6.  Synthetic peptide vaccine design: synthesis and properties of a high-density multiple antigenic peptide system.

Authors:  J P Tam
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

7.  In vivo replication and reversion to wild type of a neutralization-resistant antigenic variant of hepatitis A virus.

Authors:  S M Lemon; L N Binn; R Marchwicki; P C Murphy; L H Ping; R W Jansen; L V Asher; J T Stapleton; D G Taylor; J W LeDuc
Journal:  J Infect Dis       Date:  1990-01       Impact factor: 5.226

8.  Liver-derived cytotoxic T cells in hepatitis A virus infection.

Authors:  A Vallbracht; K Maier; Y D Stierhof; K H Wiedmann; B Flehmig; B Fleischer
Journal:  J Infect Dis       Date:  1989-08       Impact factor: 5.226

9.  Characterization of a simian hepatitis A virus (HAV): antigenic and genetic comparison with human HAV.

Authors:  E A Brown; R W Jansen; S M Lemon
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

10.  Antigenic structure of human hepatitis A virus defined by analysis of escape mutants selected against murine monoclonal antibodies.

Authors:  L H Ping; S M Lemon
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

View more
  4 in total

1.  Identification of new tag sequences with differential and selective recognition properties for the anti-FLAG monoclonal antibodies M1, M2 and M5.

Authors:  J W Slootstra; D Kuperus; A Plückthun; R H Meloen
Journal:  Mol Divers       Date:  1997       Impact factor: 2.943

2.  Structure of a high-affinity "mimotope" peptide bound to HIV-1-neutralizing antibody b12 explains its inability to elicit gp120 cross-reactive antibodies.

Authors:  Erica Ollmann Saphire; Marinieve Montero; Alfredo Menendez; Nienke E van Houten; Melita B Irving; Ralph Pantophlet; Michael B Zwick; Paul W H I Parren; Dennis R Burton; Jamie K Scott; Ian A Wilson
Journal:  J Mol Biol       Date:  2007-01-27       Impact factor: 5.469

3.  Applying bioinformatics for antibody epitope prediction using affinity-selected mimotopes - relevance for vaccine design.

Authors:  Galina F Denisova; Dimitri A Denisov; Jonathan L Bramson
Journal:  Immunome Res       Date:  2010-11-03

Review 4.  Molecular biology and inhibitors of hepatitis A virus.

Authors:  Yannick Debing; Johan Neyts; Hendrik Jan Thibaut
Journal:  Med Res Rev       Date:  2013-05-30       Impact factor: 12.944

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.